126 filings
Page 4 of 7
8-K
yo386dhy
11 May 21
Beam Therapeutics Presents LNP Formulation Data at ASGCT and Reports First Quarter 2021 Financial Results
7:48am
DEFA14A
fmkh81 q0em32cyg6y8w
23 Apr 21
Additional proxy soliciting materials
4:15pm
8-K
7na3zc7x6s uwrc
23 Apr 21
Departure of Directors or Certain Officers
4:10pm
DEF 14A
pb39u9 d1gkntn
23 Apr 21
Definitive proxy
4:05pm
424B5
rvmk8
1 Apr 21
Prospectus supplement for primary offering
8:15am
8-K
0e60 mzu5qqpy9
1 Apr 21
Other Events
7:48am
424B7
sjka2kx0it fwxz6
1 Apr 21
Prospectus with selling stockholder info
7:36am
424B7
ygmgt4g
1 Apr 21
Prospectus with selling stockholder info
7:24am
S-3ASR
pzweuofq0rn01e
1 Apr 21
Automatic shelf registration
6:08am
S-8
zifii
17 Mar 21
Registration of securities for employees
7:15am
8-K
09f44
15 Mar 21
Beam Therapeutics Announces Business and Pipeline Progress and Reports Fourth Quarter and Full Year 2020 Financial Results
6:45am
8-K
nfmooww8gcwj
23 Feb 21
Beam Therapeutics Announces Acquisition of Guide Therapeutics
8:43am
8-K
p8a6 2977fx4h68
19 Jan 21
Beam Therapeutics Inc. Announces $260 Million Common Stock Investment from Multiple Investors
6:46am
8-K
6ro10pz93e6bzk3t9uek
13 Jan 21
Regulation FD Disclosure
12:00am
8-K
c63ho zfjk9xre
12 Jan 21
Regulation FD Disclosure
7:00am
8-K
flm6ab1js6pwxtbeqa
11 Jan 21
Departure of Directors or Certain Officers
4:30pm
8-K
gzx8sbdqdb 36g0nod
10 Nov 20
Beam Therapeutics Announces Business and Pipeline Progress and Reports Third Quarter 2020 Financial Results
6:41am